-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amifostine in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amifostine in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amifostine in Radiation Toxicity (Radiation Sickness,...
-
Product Insights
Likelihood of Approval Analysis for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Overview How likely is it that the drugs in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mosedipimod in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mosedipimod in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mosedipimod in Radiation Toxicity (Radiation Sickness, Acute...
-
Product Insights
NewRadiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024
Empower your strategies with our Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Radiation toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of ionizing radiation over a very short period of time (usually a matter of minutes). The root cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from...
-
Product Insights
NewThrombopoietin Receptor – Drugs In Development, 2024
The Thrombopoietin Receptor pipeline drugs market research report outlays comprehensive information on the Thrombopoietin Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Toxicology, Gastrointestinal, and Oncology which include indications of Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), Thrombocytopenia, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Chronic Liver Disease, and Myelodysplastic Syndrome. It also reviews key...
-
Product Insights
NewNitric Oxide Synthase – Drugs In Development, 2024
The Nitric Oxide Synthase pipeline drugs market research report outlays comprehensive information on the Nitric Oxide Synthase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Oncology, and Toxicology which include indications of Traumatic Brain Injury, Neurodegenerative Diseases, Thrombosis, Pulmonary Arterial Hypertension, Melanoma, Brain Cancer, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), and Radiation...
-
Product Insights
NewInterleukin 11 Receptor – Drugs In Development, 2024
The Interleukin 11 Receptor pipeline drugs market research report outlays comprehensive information on the Interleukin 11 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Oncology, Respiratory, and Toxicology which include indications of Thrombocytopenia, Hemophilia, Colorectal Cancer, Gastric Cancer, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Chemotherapy Effects, and Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). It...
-
Product Insights
NewToll Like Receptor 5 – Drugs In Development, 2024
The Toll Like Receptor 5 pipeline drugs market research report outlays comprehensive information on the Toll Like Receptor 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Toxicology, Immunology, and Respiratory which include indications of Unspecified Cancer, Breast Cancer, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), and Idiopathic Pulmonary...
-
Product Insights
NewSuperoxide Dismutase – Drugs In Development, 2024
The Superoxide Dismutase pipeline drugs market research report outlays comprehensive information on the Superoxide Dismutase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, and Toxicology which include indications of Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, Leishmaniasis (Kala-Azar), Chagas Disease (American Trypanosomiasis), and Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). It also reviews key...